Quick Answer
Aspira Women’s Health Inc. reported Revenue (ASC 606) of $9.18 million for fiscal year 2024.
Aspira Women’s Health Inc. Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2024 | $9.18M | +0.3% |
| 2023 | $9.15M | — |
Quarterly Revenue (ASC 606)
| Quarter Ending | Revenue (ASC 606) | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $2.31M | +2.1% | -4.1% |
| June 30, 2025 | $2.40M | -0.8% | +5.5% |
| March 31, 2025 | $2.28M | +5.9% | +1.0% |
| September 30, 2024 | $2.26M | +1.8% | -6.9% |
| June 30, 2024 | $2.42M | -2.7% | +12.5% |
| March 31, 2024 | $2.15M | -7.0% | -2.9% |
| September 30, 2023 | $2.22M | — | -11.0% |
| June 30, 2023 | $2.49M | — | +7.6% |
- Aspira Women’s Health Inc. showed an increase of +0.3% in Revenue (ASC 606) compared to the prior fiscal year.
- Over the 2023–2024 period, Aspira Women’s Health Inc.’s revenue (asc 606) has grown by 0.3% (from $9.15 million to $9.18 million).
- The most recent figure is from Aspira Women’s Health Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 27, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: